Patent ID: 11865210
Assignee: VECTURA INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 0:
1. A dry powder formulation for treating or reducing risk of a thromboembolic event in a subject in need thereof, the formulation suitable for delivery from within a dry powder inhaler, the formulation comprising a pharmaceutically acceptable excipient and 95% or more by weight of acetylsalicylic acid or a pharmaceutically acceptable salt thereof, the formulation having a volume median geometric diameter (VMGD) of from about 1 μm to about 5 μm and a mass median aerodynamic diameter (MMAD) of less than 5 μm, and wherein said formulation delivers at least 50% of the administered acetylsalicylic acid to systemic circulation of the subject within about 15 minutes of administering to the subject by inhalation.